https://humanitrack-prod-static.s3.amazonaws.com/quest/6e85891188694b0fab2b9b1f636dfb9f.svg
Epidemic Response

Epidemic Response

Completed: 40%

Quest hub:

Prevention & handling of widespread infectious diseases through science and tech, with focus on COVID-19

Indefinite lifespanPeace on EarthSDG 3: Good health and well-being

Welcome!

Visitors, explore and click the tabs from DATA to EVENTS (scroll left on mobile)

What is our purpose with this Quest?

  • To create agile, interactive, and complete overviews and roadmaps of the technologies driving progress on handling and preventing COVID-19 and future epidemics, and then help accelerate that progress

How?

  • The publicly available databases and roadmaps we create as a community help align all entities working on solutions and identify where to focus efforts and resources for maximum impact
  • Enable anyone, even non-technical people, to take action to fight COVID-19 with science, technology, and innovation via our tasks
  • Provide an open source pre-projecting platform to nurture ideas and breed innovation for new and improved solutions
  • This all leads to making the most of our global resources, collaboration, and impact to accelerate progress on the most ideal, affordable, and sustainable solutions

Want to help?

  • Become a Hero and JOIN NOW (is free, takes 10 minutes here and there)
  • Join our growing volunteering team of researchers, ambassadors, content creators, communicators, moderators...more info and sign-up HERE
  • Spread the word: follow, like, tag, share! Insta LinkedIn FB Twitter
  • Show some love via our Support page

Heroes and volunteers, go take action with a Task, be vocal in the Labs, or post in the newsfeed!

 

Read our community written articles on...

 

Current community goal: Reach 200 followers for this Quest! Expand the Progress Bar above to see the status

Check out our curated list of COVID-19 resources below from our LIBRARY section...

Quest leaderboard

Join to post in feed

Sep 14, 2020

https://scitechdaily.com/computer-designed-synthetic-antiviral-proteins-inhibit-sars-cov-2-covid-19-in-human-cells/

Computer-designed small proteins have now been shown to protect lab-grown human cells from SARS-CoV-2, the coronavirus that causes COVID-19. In the experiments, the lead antiviral candidate, named LCB1, rivaled the best-known SARS-CoV-2 neutralizing antibodies in its protective actions.


1
Leave the first comment

Sep 14, 2020

https://scitechdaily.com/ab8-covid-19-drug-breakthrough-tiny-antibody-component-completely-neutralizes-the-sars-cov-2-virus/

University of Pittsburgh School of Medicine scientists have isolated the smallest biological molecule to date that completely and specifically neutralizes the SARS-CoV-2 virus, which is the cause of COVID-19. This antibody component, which is 10 times smaller than a full-sized antibody, has been used to construct a drug — known as Ab8 — for potential use as a therapeutic and prophylactic against SARS-CoV-2.


1
Leave the first comment

Sep 14, 2020

https://www.protocols.io/workspaces/xprct

Super cool workspace for the XPRIZE Rapid Covid Testing competition! Go check out many of these solutions from the open-science community.


2
Leave the first comment

Sep 13, 2020

https://www.livescience.com/amp/brain-invasion-coronavirus.html

The coronavirus that causes COVID-19 can sometimes hijack brain cells, using the cells' internal machinery to copy itself, according to a new study.


2
Leave the first comment

Sep 13, 2020

https://www.propublica.org/article/new-research-shows-disproportionate-rate-of-coronavirus-deaths-in-polluted-areas/amp

The type of pollution emitted by many chemical plants in Louisiana's industrial corridor is correlated with increased coronavirus deaths, according to new peer-reviewed research from SUNY and ProPublica.


2
Leave the first comment

Sep 13, 2020

https://www.npr.org/sections/health-shots/2020/09/12/911987987/a-covid-19-vaccine-may-be-only-50-effective-is-that-good-enough?t=1599986815190

As we get closer to a COVID-19 vaccine, it's exciting to imagine a day when the virus is gone. But a vaccine will not be a magic bullet. In fact, it may be only about 50% effective.

SDG 3: Good health and well-being

2
Leave the first comment

Sep 11, 2020

Humanitrack's overview of the latest and coming drug therapies for COVID-19 like Dexamethasone which has reduced mortality by 1/3rd for patients on ventilators, or other therapies like the exciting artificial antibodies like mNb6-tri (AeroNabs).


3
Leave the first comment

Sep 07, 2020

https://www.ecronicon.com/ecpt/ECPT-08-00524.php

We used molecular docking as an approach to evaluate the binding energies of some already approved anti-parasitic drugs for their binding affinities to the main protease of COVID-19, otherwise known as the 3C-like protease or 3CL pro, (PDB ID: 6LU7). Molecular docking (blind) was done with the help of Autodock Vina. It was observed that of the seven drugs tested, two drugs, namely praziquantel (used for schistosomiasis) and amphotericin B (an antifungal drug) showed good binding energies with the protease and so merit further study for their potential use as therapeutic agents for COVID-19.

SDG 3: Good health and well-being

2
Leave the first comment

Sep 03, 2020

https://www.sciencedaily.com/releases/2020/09/200902091108.htm

A blood test on hospital admission showing the presence or absence of SARS-CoV-2 can identify patients at a high risk of severe COVID-19, according to researchers. Admitted patients without virus in their blood have a good chance of rapid recovery.

SDG 3: Good health and well-being
covid-19
RNA
+ 1 more

1
Leave the first comment

Sep 03, 2020

https://factor.niehs.nih.gov/2020/9/feature/2-feature-glucocorticoid-drug/index.htm

Dexamethasone reduces dangerous inflammation seen late in the disease, say an NIEHS scientist and his collaborator. A synthetic glucocorticoid, dexamethasone is used for decades to treat conditions ranging from arthritis to immune system disorders.


1
Leave the first comment